AI assistant
Sending…
VOLITIONRX LTD — Director's Dealing 2016
Apr 19, 2016
34395_dirs_2016-04-19_3aae4b6d-3de8-49f6-b4a5-b72cf480f397.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: VOLITIONRX LTD (VNRX)
CIK: 0000093314
Period of Report: 2016-04-15
Reporting Person: Colman Alan (Director)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2016-04-15 | Stock Option (Right to Buy) | $4 | A | 20000 | Acquired | 2022-04-15 | Common Stock (20000) | Direct |
Footnotes
F1: A total of 20,000 Options were granted on April 15, 2016 under the Company's 2015 Stock Incentive Plan. The Options vest in full twelve months from the date of grant.
More from VOLITIONRX LTD
Regulatory Filings
2026
May 22
Regulatory Filings
2026
May 15
Interim / Quarterly Report
2026
May 14
Regulatory Filings
2026
May 14
Regulatory Filings
2026
May 13
Annual Report
2026
Apr 30
Regulatory Filings
2026
Apr 28
Regulatory Filings
2026
Apr 23
Regulatory Filings
2026
Apr 17
Regulatory Filings
2026
Apr 1